Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Seoul
Clinical trial register · South Korea

Clinical Trials in Seoul, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Goyang-si 23 Seoul 10 Goyang 5 Busan 3 Suwon 2
Narrow the registerReset
Recruitment status
Phase
Site location
Goyang-si23 Seoul10 Goyang5 Busan3 Suwon2
All 16 locations
Target enrolment
to

Trials with a site in Seoul

10 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
National Cancer Center, Korea
Phase 2
128
Goyang, Seoul
2025-04-15
By invitation
Active Surveillance for Low-risk Papillary Thyroid Carcinoma
NCT06261190Thyroid Cancer, Papillary Thyroid Carcinoma
National Cancer Center, Korea
Observational
499
Goyang-si, Seongnam, Seoul
2024-03-06
Recruiting
National Cancer Center, Korea
Not applicable
120
Goyang-si, Seoul
2023-12-27
Recruiting
National Cancer Center, Korea
Phase 2
120
Suwon, Goyang-si, Seoul
2023-09-05
Not yet open
National Cancer Center, Korea
Not applicable
203
Busan, Gyeongsang, Seoul, Gyeonggi-do, Changwon
2023-08-17
Recruiting
National Cancer Center, Korea
Phase 3
520
Sejong, Goyang-si, Suwon, Pusan, Seoul
2023-05-31
Active, closed
CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
NCT05316181Epithelial Ovarian Cancer, Platinum Resistant, Recurrent Ovarian, HIPEC
National Cancer Center, Korea
Phase 3
140
Goyang-si, Seoul
2022-04-07
Recruiting
National Cancer Center, Korea
Phase 3
1,700
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul
2020-02-15
Active, closed
National Cancer Center, Korea
Phase 2
284
Seoul
2019-01-15
Active, closed
Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
NCT02112214Gastric Cancer, Helicobacter Pylori Infection
National Cancer Center, Korea
Phase 3
5,224
Busan, Chuncheon, Daegu, Goyang, Gwangju, Incheon, Seoul, Uijeongbu-si
2014-06
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seoul

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Seoul that also match the filters currently applied.

How many clinical trials are recruiting in Seoul?

5 of the 10 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seoul), 10 studies
PhaseStudiesRecruitingShare
Phase 34240%
Phase 23230%
Not applicable2120%
Observational1010%

Most active sponsors

Lead sponsors with the most studies (Seoul)
Lead sponsorStudiesRecruiting
National Cancer Center, Korea105
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.